BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34086694)

  • 61. Management of High and Very High-Risk Subjects with Familial Hypercholesterolemia: Results from an Observational Study in Bulgaria.
    Petrov IS; Postadzhiyan AS; Tokmakova MP; Kitova LG; Tsonev SN; Addison J; Petkova RT; Lachev VI
    Folia Med (Plovdiv); 2018 Sep; 60(3):389-396. PubMed ID: 30355848
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence and Treatment of Familial Hypercholesterolemia in France.
    Bérard E; Bongard V; Haas B; Dallongeville J; Moitry M; Cottel D; Ruidavets JB; Ferrières J
    Can J Cardiol; 2019 Jun; 35(6):744-752. PubMed ID: 31151710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
    Korneva V; Kuznetsova T; Julius U
    Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Familial Hypercholesterolemia: Advances in Recognition and Therapy.
    Cartier JL; Goldberg AC
    Prog Cardiovasc Dis; 2016; 59(2):125-134. PubMed ID: 27477957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
    Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
    Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care.
    Balla S; Ekpo EP; Wilemon KA; Knowles JW; Rodriguez F
    Curr Atheroscler Rep; 2020 Aug; 22(10):60. PubMed ID: 32816232
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis and treatment of familial hypercholesterolaemia.
    Hovingh GK; Davidson MH; Kastelein JJ; O'Connor AM
    Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experience.
    Galema-Boers AMH; Lenzen MJ; Sijbrands EJ; Roeters van Lennep JE
    J Clin Lipidol; 2017; 11(3):674-681. PubMed ID: 28506389
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 Inhibitors.
    Razek O; Cermakova L; Armani H; Lee T; Francis GA; Mancini GBJ; Frohlich J; Brunham LR
    Can J Cardiol; 2018 Aug; 34(8):1004-1009. PubMed ID: 30056842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries.
    Aljulifi MZ
    Saudi Med J; 2021 May; 42(5):481-490. PubMed ID: 33896777
    [TBL] [Abstract][Full Text] [Related]  

  • 74. My Approach to the Patient With Familial Hypercholesterolemia.
    Safarova MS; Kullo IJ
    Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
    [TBL] [Abstract][Full Text] [Related]  

  • 75. LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis.
    Schreuder MM; Hamkour S; Siegers KE; Holven KB; Johansen AK; van de Ree MA; Imholz B; Boersma E; Louters L; Bogsrud MP; Retterstøl K; Visseren FLJ; Roeters van Lennep JE; Koopal C
    Atherosclerosis; 2023 Nov; 384():117117. PubMed ID: 37080805
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Forecasting the SARS COVID-19 pandemic and critical care resources threshold in the Gulf Cooperation Council (GCC) countries: population analysis of aggregate data.
    Al-Aamri AK; Al-Harrasi AA; AAl-Abdulsalam AK; Al-Maniri AA; Padmadas SS
    BMJ Open; 2021 May; 11(5):e044102. PubMed ID: 33980523
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe.
    Ruel I; Aljenedil S; Sadri I; de Varennes É; Hegele RA; Couture P; Bergeron J; Wanneh E; Baass A; Dufour R; Gaudet D; Brisson D; Brunham LR; Francis GA; Cermakova L; Brophy JM; Ryomoto A; Mancini GBJ; Genest J
    Clin Chem; 2018 Feb; 64(2):355-362. PubMed ID: 29038147
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice.
    Catapano AL; Lautsch D; Tokgözoglu L; Ferrieres J; Horack M; Farnier M; Toth PP; Brudi P; Tomassini JE; Ambegaonkar B; Gitt AK
    Atherosclerosis; 2016 Sep; 252():1-8. PubMed ID: 27494444
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Past, Present, and Future of Familial Hypercholesterolemia Management.
    Rocha VZ; Santos RD
    Methodist Debakey Cardiovasc J; 2021; 17(4):28-35. PubMed ID: 34824679
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).
    AlYousef A; AlGhareeb S; Al Wakeel J; Al-Ghamdi SM; Bieber BA; Hassan M; Al Maimani Y; Alkandari N; Ahmed HZ; Fawzy A; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):S42-50. PubMed ID: 27991478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.